scholarly journals Are There Differences between Macrocyclic Gadolinium Contrast Agents for Brain Tumor Imaging? Results of a Multicenter Intraindividual Crossover Comparison of Gadobutrol with Gadoteridol (the TRUTH Study)

2014 ◽  
Vol 36 (1) ◽  
pp. 14-23 ◽  
Author(s):  
K. R. Maravilla ◽  
M. P. Smith ◽  
J. Vymazal ◽  
M. Goyal ◽  
M. Herman ◽  
...  
Keyword(s):  
Brain Tumor ◽  
Contrast Agents ◽  
Tumor Imaging ◽  
Gadolinium Contrast ◽  
Imaging Results ◽  
Gadolinium Contrast Agents ◽  
Crossover Comparison

scholarly journals MRI in Pregnancy and Precision Medicine: A Review from Literature

2021 ◽  
Vol 12 (1) ◽  
pp. 9
Author(s):  
Gianluca Gatta ◽  
Graziella Di Grezia ◽  
Vincenzo Cuccurullo ◽  
Celestino Sardu ◽  
Francesco Iovino ◽  
...  
Keyword(s):  
Contrast Agents ◽  
Blood Pool ◽  
Placental Barrier ◽  
Negative Effects ◽  
Gadolinium Contrast ◽  
Imaging Results ◽  
Gadolinium Contrast Agents ◽  
Magnetic Resonance Imaging Mri ◽  
Abdominal And Pelvic Pain ◽  
Ionizing Radiations

Magnetic resonance imaging (MRI) offers excellent spatial and contrast resolution for evaluating a wide variety of pathologies, without exposing patients to ionizing radiations. Additionally, MRI offers reproducible diagnostic imaging results that are not operator-dependent, a major advantage over ultrasound. MRI is commonly used in pregnant women to evaluate, most frequently, acute abdominal and pelvic pain or placental abnormalities, as well as neurological or fetal abnormalities, infections, or neoplasms. However, to date, our knowledge about MRI safety during pregnancy, especially about the administration of gadolinium-based contrast agents, which are able to cross the placental barrier, is still limited, raising concerns about possible negative effects on both the mother and the health of the fetus. Contrast agents that are unable to cross the placenta in a way that is safe for the fetus are desirable. In recent years, some preclinical studies, carried out in rodent models, have evaluated the role of long circulating liposomal nanoparticle-based blood-pool gadolinium contrast agents that do not penetrate the placental barrier due to their size and therefore do not expose the fetus to the contrast agent during pregnancy, preserving it from any hypothetical risks. Hence, we performed a literature review focusing on contrast and non-contrast MRI use during pregnancy.

Clinical value of negative skin tests to gadolinium contrast agents

Allergy ◽  
2011 ◽  
Vol 66 (11) ◽  
pp. 1504-1506 ◽  
Author(s):  
A.-M. Chiriac ◽  
Y. Audurier ◽  
P. -J. Bousquet ◽  
P. Demoly
Keyword(s):  
Contrast Agents ◽  
Skin Tests ◽  
Clinical Value ◽  
Gadolinium Contrast ◽  
Gadolinium Contrast Agents

scholarly journals Native T1-mapping detects the location, extent and patterns of acute myocarditis without the need for gadolinium contrast agents

2014 ◽  
Vol 16 (1) ◽  
Author(s):  
Vanessa M Ferreira ◽  
Stefan K Piechnik ◽  
Erica Dall’Armellina ◽  
Theodoros D Karamitsos ◽  
Jane M Francis ◽  
...  
Keyword(s):  
Contrast Agents ◽  
T1 Mapping ◽  
Acute Myocarditis ◽  
Gadolinium Contrast ◽  
Native T1 ◽  
Gadolinium Contrast Agents
Sign in / Sign up

Export Citation Format

Share Document